Thomas Reiner
Chief Scientific Officer Evergreen Theragnostics
Seminars
Wednesday 30th July 2025
Drug Discovery in the Age of Radioligand Therapies
12:00 pm
• What are RLTs, how do they work and why are we so excited about them?
• What new approaches is Lantheus working on to take RLTs to the next level?
• What challenges will we face in the future as a field, and what could be our next leap to change the practice of medicine with RLTs?
